
Pharmaceutical company Novo Nordisk is currently looking into the possibility of repurposing used insulin pens.
"We produce more than 700 million insulin pens annually for people with diabetes, and we're interested in ensuring they put as little strain on the environment as possible," says General Manager, Novo Nordisk Denmark & Iceland Kasper Bødker Mejlvang.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app